Spots Global Cancer Trial Database for bladder cancer
Every month we try and update this database with for bladder cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combined Use of BCG and Interferon Alpha in Bladder Cancer | NCT00330707 | Carcinoma of Ur... | Bacillus Calmet... | 18 Years - | National University Hospital, Singapore | |
| Bristol Bladder Trial | NCT01616875 | Infiltrating Bl... | Cabazitaxel + C... | 18 Years - | University Hospitals Bristol and Weston NHS Foundation Trust | |
| A 12-Gene Blood-Based Signature for Detecting Metastatic Bladder Cancer | NCT00918008 | Bladder Cancer | Blood draw | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) | NCT04198766 | Solid Tumor Non-Small Cell ... Melanoma Head and Neck C... Gastric Cancer Renal Cell Carc... Urothelial Carc... | INBRX-106 - Hex... Pembrolizumab 2... Pembrolizumab 4... | 18 Years - | Inhibrx, Inc. | |
| Efficacy of Diclofenac BCG Irrigations | NCT01542567 | Bladder Cancer | Abitren Placebo | 20 Years - 80 Years | Carmel Medical Center | |
| Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer | NCT00380029 | Bladder Cancer | Erlotinib Radical Cystect... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors | NCT00471432 | Bladder Cancer Breast Cancer Kidney Cancer Lung Cancer Ovarian Cancer Prostate Cancer Unspecified Adu... | custirsen sodiu... docetaxel pharmacological... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Integrated Care Pathway in Oncology (PASSION) | NCT04235556 | Colon Cancer Gastric Cancer Pancreatic Canc... Thoracic Neopla... Breast Cancer Ovarian Cancer Bladder Cancer Prostate Cancer | Care pathway un... | 18 Years - 80 Years | Assistance Publique - Hôpitaux de Paris | |
| The Personal Patient Profile Decision Support for Patients With Bladder Cancer | NCT05033067 | Bladder Cancer | P3BC | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer | NCT05085990 | Non-muscle Inva... | TARA-002 | 18 Years - | Protara Therapeutics | |
| CARINAE for Stress Relief in Perioperative Care | NCT05184725 | Psychological S... Cardiopulmonary... Coronary Artery... Cardiac Valve R... Hip Replacement Orthognathic Su... Scoliosis Knee Replacemen... Prostate Cancer Kidney Cancer Bladder Cancer | SaMD CARINAE | 8 Years - | Adhera Health, Inc. | |
| Comparison of the Application of Robot-assisted Laparoscopic Pathways in Radical Cystectomy | NCT06253091 | Bladder Cancer | robit-assist ex... | 18 Years - 75 Years | The First Affiliated Hospital with Nanjing Medical University | |
| Information Improvement for Surgical Patients Through Portable Video Media | NCT02846467 | Prostatic Hyper... Bladder Cancer | Informed consen... Written informe... | 18 Years - | Hospital Universitario Puerto Real | |
| Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy | NCT04068896 | Pancreatic Canc... Metastatic Cast... Bladder Cancer Melanoma Non-small Cell ... Colorectal Canc... Gastric Cancer Esophageal Canc... Ovarian Cancer Head Neck Squam... Prostate Cancer | NGM120 NGM120 NGM120 NGM120 NGM120 NGM120 Placebo | 18 Years - | NGM Biopharmaceuticals, Inc | |
| Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium | NCT00805129 | Bladder Cancer Metastatic Tran... | Everolimus | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies | NCT04383938 | Bladder Cancer Gastric Cancer Non Small Cell ... NSCLC Urothelial Carc... Advanced Solid ... | APR-246 (eprene... | 18 Years - | Aprea Therapeutics | |
| Cabozantinib for Advanced Urothelial Cancer | NCT01688999 | Urothelial Carc... Urethral Neopla... Urinary Bladder... Kidney Neoplasm... | Cabozantinib | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| SArcopenia, Mobility, PHYsical Activity and Post-operative Risk of Bladder Carcinoma in the Elderly | NCT03362801 | Sarcopenia Bladder Cancer | sarcopenia and ... | 65 Years - | University Hospital, Caen | |
| Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression | NCT02443844 | Bladder Cancer | Transurethral R... Tamsulosin | 40 Years - 80 Years | Diskapi Teaching and Research Hospital | |
| Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy | NCT00310115 | Bladder Cancer Cervical Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Kidney Cancer Leukemia Liver Cancer Lung Cancer Pancreatic Canc... Tobacco Use Dis... | Smoking Prevent... Counseling Inte... Counseling Inte... | 18 Years - | M.D. Anderson Cancer Center | |
| Role of FDG-PET CT in the Management of Muscle Invasive Bladder Cancer | NCT04053101 | Muscle Invasive... | PET CT | 18 Years - | Institut Bergonié | |
| S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract | NCT00014144 | Bladder Cancer Transitional Ce... Urethral Cancer | gefitinib | - | SWOG Cancer Research Network | |
| One Time Injection of Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy | NCT00358397 | Tumors | Clostridium nov... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Efficacy and Safety Study of Apaziquone vs. Placebo in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC) | NCT01469221 | Bladder Cancer | Apaziquone Placebo | 18 Years - | Spectrum Pharmaceuticals, Inc | |
| Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter | NCT00066352 | Bladder Cancer Transitional Ce... | bortezomib | 18 Years - | University Health Network, Toronto | |
| Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma | NCT00714948 | Bladder Cancer URINARY BLADDER | gemcitabine and... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Sequential Combination Therapy in Bladder Cancer | NCT03790384 | Bladder Cancer | Mitomycin | 30 Years - | Azienda Ospedaliera "Sant'Andrea" | |
| Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ | NCT00462488 | Urinary Bladder... Bladder Cancer Bladder Neoplas... Bladder Tumors | Vicinium | 18 Years - | Sesen Bio, Inc. | |
| Fiber-Optic Confocal Microscopy of the Urinary Tract Histopathology | NCT00801762 | Bladder Cancer | Fibered confoca... | - | Stanford University | |
| The Personal Patient Profile Decision Support for Patients With Bladder Cancer | NCT05033067 | Bladder Cancer | P3BC | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer | NCT00003759 | Bladder Cancer | BCG vaccine valrubicin conventional su... | 18 Years - | National Cancer Institute (NCI) | |
| Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2) | NCT06225596 | Metastatic Urot... | BT8009 BT8009 BT8009 Pembrolizumab Gemcitabine + c... Avelumab | 18 Years - | BicycleTx Limited | |
| The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients | NCT00859768 | Breast Cancer Lung Cancer Prostate Cancer Bladder Cancer Cervix Cancer Cancer of Endom... Cancer of Skin Non-Hodgkin Lym... Colorectal Canc... | Questionnaire a... | 18 Years - | Netherlands Open University | |
| Long-Term Outcomes of Robot-Assisted Radical Cystectomy: A Real-World Study | NCT05856825 | Bladder Cancer Robot-assisted ... | Robot-assisted ... | 18 Years - | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder Tumors | NCT01567462 | Bladder Cancer | Monopolar elect... PK Button Vapor... | 18 Years - 89 Years | Emory University | |
| Enfortumab Vedotin and Stereotactic Radiation for Localized, Cisplatin Ineligible Muscle Invasive Bladder Cancer | NCT06394570 | Bladder Cancer | Enfortumab vedo... | 18 Years - | University of Texas Southwestern Medical Center | |
| Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer. | NCT05102110 | Non Small Cell ... Gastric Adenoca... Pancreatic Canc... Gall Bladder Ca... Bladder Cancer | Oricol Test | 18 Years - 99 Years | Origin Sciences | |
| Basal Tumours in Bladder Cancer, Response to chemoTherapy | NCT04089748 | Bladder Cancer Chemotherapy Ef... | neoadjuvant che... | 18 Years - 80 Years | University Hospital, Rouen | |
| Bladder Cancer and Neoadjuvant Chemotherapy Efficiency Before Cystectomy | NCT06294054 | Bladder Cancer Genomic Instabi... | neoadjuvant che... | 18 Years - 80 Years | University Hospital, Rouen | |
| Checkpoint Inhibitor and Radiation Therapy in Bulky, Node-Positive Bladder Cancer | NCT04779489 | Bladder Cancer | personalized ul... | 18 Years - | University of Texas Southwestern Medical Center | |
| Tranexamic Acid During Cystectomy Trial (TACT) | NCT01869413 | Bladder Cancer | Tranexamic Acid Placebo | 18 Years - | Ottawa Hospital Research Institute | |
| Novel mRNA-based Urine Test for Bladder Cancer in Spinal Cord Injury Individuals | NCT02538809 | Bladder Cancer Spinal Cord Inj... | measurement of ... | 18 Years - | Swiss Paraplegic Research, Nottwil | |
| Clinical Investigation of the Multi4 System | NCT06136312 | Bladder Cancer | Multi4 | 18 Years - | Multi4 Medical Ab | |
| A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours | NCT04969835 | Pancreatic Canc... Colorectal Canc... Non-small Cell ... Head and Neck C... Cancer of Unkno... Ovarian Cancer Breast Cancer Soft Tissue Sar... Bladder Cancer Oesophageal Can... Prostate Cancer Biliary Tract C... | AVA6000 | 18 Years - | Avacta Life Sciences Ltd | |
| Hypofractionated IMRT With Concurrent Chemotherapy in Muscle-invasive Bladder Cancer (HIRACUM) | NCT05453682 | Bladder Cancer | hypo-IMRT | 20 Years - | Samsung Medical Center | |
| CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | NCT04660929 | HER2-positive Adenocarcinoma Bile Duct Cance... Biliary Tract C... Bladder Cancer Breast Cancer Breast Neoplasm Carcinoma, Duct... Carcinoma, Hepa... Cancer Lung Cancer, No... Carcinoma, Ovar... Carcinoma, Smal... Carcinoma, Squa... Carcinoma, Tran... Colorectal Canc... Esophagogastric... Inflammatory Br... Stomach Neoplas... Malignant Neopl... Ovarian Neoplas... Pancreatic Canc... HER2-positive S... HER2-positive B... HER2-positive G... HER-2 Protein O... HER-2 Gene Ampl... Prostate Cancer Head and Neck C... Endometrial Can... Lung Cancer, Sm... | CT-0508 Pembrolizumab | 18 Years - | Carisma Therapeutics Inc | |
| Clinical Study to Investigate the Safety and Tolerance of Therapeutic BCG in Postoperative Adjuvant Therapy in Subjects With Moderate to High-risk Non-muscular Invasive Bladder Cancer (NMIBC) | NCT06350838 | Non-muscular In... | BCG for Therape... | 18 Years - 85 Years | Chengdu CoenBiotech Co., Ltd | |
| Using PROMIS as Part of Routine Clinical Care for Racially Diverse Prostate and Bladder Cancer Patients | NCT03156244 | Prostate Cancer Bladder Cancer | 18 Years - | UNC Lineberger Comprehensive Cancer Center | ||
| Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB | NCT01166230 | Bladder Cancer | 18 Years - | Photocure | ||
| Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention | NCT04555343 | Urologic Diseas... Prostate Cancer Bladder Cancer Urinary Retenti... Hematuria Nurse Physician... Nurse's Role Patient Satisfa... | Tranexamic acid | 18 Years - | Fraser Health | |
| Mind-Body Health in Uro-Oncology: Research Study | NCT03852030 | Prostate Cancer Kidney Cancer Bladder Cancer | Text or email m... | 18 Years - | Northwestern University | |
| A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours | NCT04969835 | Pancreatic Canc... Colorectal Canc... Non-small Cell ... Head and Neck C... Cancer of Unkno... Ovarian Cancer Breast Cancer Soft Tissue Sar... Bladder Cancer Oesophageal Can... Prostate Cancer Biliary Tract C... | AVA6000 | 18 Years - | Avacta Life Sciences Ltd | |
| Analyzing the Urine During BCG Instillation in Bladder Cancer Patients for Disease Followup | NCT06153849 | Bladder Cancer | urine sample co... | 18 Years - 99 Years | Changhai Hospital | |
| SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry | NCT03452774 | Cancer, Metasta... Cancer Cancer of Pancr... Cancer of Liver Cancer of Stoma... Cancer Liver Cancer of Rectu... Cancer of Kidne... Cancer of Esoph... Cancer of Cervi... Cancer of Colon Cancer of Laryn... Cancer, Lung Cancer, Breast Cancer, Advance... Cancer Prostate Cancer of Neck Cancer of Skin Neuroendocrine ... Carcinoma Mismatch Repair... BRCA Gene Rearr... Non Hodgkin Lym... Leukemia Non Small Cell ... Cholangiocarcin... Glioblastoma Central Nervous... Melanoma Urothelial Carc... Bladder Cancer Ovarian Cancer Endometrial Can... Testicular Canc... Breast Cancer COVID Myelofibrosis Myeloproliferat... Myeloproliferat... Follicular Lymp... Mantle Cell Lym... Marginal Zone L... Myelodysplastic... | Clinical Trial ... | - | Massive Bio, Inc. | |
| Bakircay University Cigli Training and Research Hospital | NCT04683536 | Bladder Cancer | Obturator nerve... | - | Recep Tayyip Erdogan University Training and Research Hospital | |
| RAD001 and Intravesical Gemcitabine in BCG-Refractory Primary or Secondary Carcinoma In Situ of the Bladder | NCT01259063 | Bladder Cancer | Everolimus and ... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder | NCT05137262 | Urothelial Carc... Bladder Cancer | Abiraterone ace... Durvalumab Methotrexate Vinblastine Doxorubicin Hyd... Cisplatin | 18 Years - | M.D. Anderson Cancer Center | |
| Intravesical BCG Administration to Patients With Invasive Bladder Cancer | NCT02365207 | Bladder Cancer | BCG strain of M... | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| Urothelial Cancer Tumor Bio-markers and Physical-spectroscopic Characteristic | NCT04770974 | Urothelial Carc... Bladder Cancer Urothelial Neop... Urothelial Carc... Urothelial Carc... | Biomarkers and ... | 18 Years - | University of Florence | |
| Comparative Microbial Analysis of Cystitis in Non-muscle-invasive Bladder Cancer Patients Using Vikor Scientific Urine-ID Testing Menu (IDTM) and Standard Laboratory Culture | NCT04583553 | Urinary Tract I... Bladder Cancer | Vikor Scientifi... | 18 Years - | University of Kansas Medical Center | |
| Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer | NCT00003342 | Bladder Cancer Transitional Ce... | filgrastim carboplatin doxorubicin hyd... gemcitabine hyd... paclitaxel | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Comparison of Safety and Efficacy of Detaenial Sigmoid Neobladder and Ileal Neobladder | NCT03108196 | Bladder Cancer Urinary Diversi... | sigmoid ileal | 18 Years - 100 Years | Zhujiang Hospital | |
| Exploring Engagement Dynamics Among Individuals Impacted by Bladder Cancer | NCT06009510 | Bladder Cancer | 18 Years - | Power Life Sciences Inc. | ||
| Cone Beam Computed Tomography (CT) Bladder | NCT00913536 | Bladder Cancer | Using Cone beam... | 18 Years - | University Health Network, Toronto | |
| MOdified Urinary Conduit to Lower Strictures After radIcal Cystectomy | NCT04391790 | Bladder Cancer | Cystectomy and ... Cystectomy and ... | 18 Years - | Aarhus University Hospital | |
| A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2 (HER2) Overexpressing Solid Tumors | NCT02999672 | Bladder Cancer Pancreas Cancer Cholangiocellul... | Trastuzumab Emt... | 18 Years - | Hoffmann-La Roche | |
| Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | NCT00024349 | Bladder Cancer | fluorouracil mitomycin C radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Incontinent Urinary Diversion Using an Autologous Neo-Urinary Conduit | NCT01087697 | Bladder Cancer | Neo-Urinary Con... | 18 Years - 80 Years | Tengion | |
| Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer | NCT03379909 | Superficial Bla... Bladder Cancer | Metformin | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder | NCT05512377 | Pancreatic Neop... Solid Tumors Biliary Tract C... Lung Neoplasms Bladder Cancer | brigimadlin | 18 Years - | Boehringer Ingelheim | |
| Adjuvant Nivolumab Following Chemo-Radiation in Localized Muscle-Invasive Bladder Cancer | NCT03171025 | Bladder Cancer | Nivolumab | 18 Years - | University of Utah | |
| Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel | NCT01668459 | Transitional Ce... | Cabazitaxel Best Supportive... | 18 Years - | University Hospital Birmingham NHS Foundation Trust | |
| Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection | NCT02852564 | Bladder Cancer | Ethacrynic Acid | 18 Years - | University of Kansas Medical Center | |
| Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma | NCT00413075 | Solid Tumor Lymphoma | oral belinostat | 18 Years - | Valerio Therapeutics | |
| TAS-116 Plus Palbociclib in Breast and Rb-null Cancer | NCT05655598 | Advanced Breast... Treatment-Refra... Retinoblastoma ... SCLC Soft Tissue Sar... Endometrial Can... Bladder Cancer | Palbociclib Ora... TAS-116 TAS-116 TAS-116 | 18 Years - | Brown University | |
| TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers | NCT04485013 | Cancer | TTX-080 TTX-080 pembrolizumab cetuximab | 18 Years - | Tizona Therapeutics, Inc | |
| Bacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma | NCT00794950 | Urinary Tract U... | Sunitinib | 18 Years - | University of Michigan | |
| Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC | NCT05768347 | Urothelial Carc... Non-Invasive Bl... | Adoptive Cell T... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Validation of VI-RADS for the Detection of Detrusor Muscle Invasion | NCT05123404 | Bladder Cancer | multi parametri... transurethral r... | - | Egyptian Biomedical Research Network | |
| Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors | NCT02897375 | Solid Neoplasm Stage III Pancr... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Non-Sm... Stage IVA Pancr... Stage IVB Pancr... Sarcoma Colorectal Canc... Head and Neck C... Cancer of Unkno... Bladder Cancer Ovarian Cancer | Carboplatin Cisplatin Palbociclib | 18 Years - | Emory University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
